- Home
- XBP vs BLUE Comparison
XBP vs BLUE Comparison
Compare XBP & BLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBP
- BLUE
- Stock Information
- Founded
- XBP N/A
- BLUE 1992
- Country
- XBP United Kingdom
- BLUE United States
- Employees
- XBP N/A
- BLUE N/A
- Industry
- XBP Business Services
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XBP Consumer Discretionary
- BLUE Health Care
- Exchange
- XBP Nasdaq
- BLUE Nasdaq
- Market Cap
- XBP 32.2M
- BLUE 36.9M
- IPO Year
- XBP N/A
- BLUE 2013
- Fundamental
- Price
- XBP $1.02
- BLUE $4.97
- Analyst Decision
- XBP
- BLUE Hold
- Analyst Count
- XBP 0
- BLUE 7
- Target Price
- XBP N/A
- BLUE $44.60
- AVG Volume (30 Days)
- XBP 34.2K
- BLUE 1.1M
- Earning Date
- XBP 05-15-2025
- BLUE 05-14-2025
- Dividend Yield
- XBP N/A
- BLUE N/A
- EPS Growth
- XBP N/A
- BLUE N/A
- EPS
- XBP N/A
- BLUE N/A
- Revenue
- XBP $142,332,000.00
- BLUE $103,946,000.00
- Revenue This Year
- XBP N/A
- BLUE $205.45
- Revenue Next Year
- XBP N/A
- BLUE $3.74
- P/E Ratio
- XBP N/A
- BLUE N/A
- Revenue Growth
- XBP N/A
- BLUE 127.51
- 52 Week Low
- XBP $0.79
- BLUE $3.20
- 52 Week High
- XBP $2.27
- BLUE $28.60
- Technical
- Relative Strength Index (RSI)
- XBP 44.62
- BLUE 62.83
- Support Level
- XBP $1.01
- BLUE $4.40
- Resistance Level
- XBP $1.13
- BLUE $5.03
- Average True Range (ATR)
- XBP 0.08
- BLUE 0.09
- MACD
- XBP -0.01
- BLUE 0.05
- Stochastic Oscillator
- XBP 27.27
- BLUE 96.72
About XBP XBP Europe Holdings Inc.
XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology, focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.